Literature DB >> 11788577

Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo.

Matthias Selbach1, Stefan Moese, Christof R Hauck, Thomas F Meyer, Steffen Backert.   

Abstract

The gastric pathogen Helicobacter pylori uses a type IV secretion system to inject the bacterial CagA protein into gastric epithelial cells. Within the host cell, CagA becomes phosphorylated on tyrosine residues and initiates cytoskeletal rearrangements. We demonstrate here that Src-like protein-tyrosine kinases mediate CagA phosphorylation in vitro and in vivo. First, the Src-specific tyrosine kinase inhibitor PP2 specifically blocks CagA phosphorylation and cytoskeletal rearrangements thereby inhibiting the CagA-induced hummingbird phenotype of gastric epithelial cells. Second, CagA is in vivo phosphorylated by transiently expressed c-Src. Third, recombinant c-Src and lysates derived from c-Src-expressing fibroblasts but not lysates derived from Src-, Yes-, and Fyn-deficient cells phosphorylated CagA in vitro. Fourth, a transfected CagA-GFP fusion protein is phosphorylated in vivo in Src-positive fibroblasts but not in Src-, Yes-, and Fyn-deficient cells. Because a CagA-GFP fusion protein mutated in an EPIYA motif is not efficiently phosphorylated in any of these fibroblast cells, the CagA EPIYA motif appears to constitute the major c-Src phosphorylation site conserved among CagA-positive Helicobacter strains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788577     DOI: 10.1074/jbc.C100754200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  162 in total

1.  The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus.

Authors:  Kevin M Bourzac; Laura A Satkamp; Karen Guillemin
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  cag+ Helicobacter pylori induces homotypic aggregation of macrophage-like cells by up-regulation and recruitment of intracellular adhesion molecule 1 to the cell surface.

Authors:  Stefan Moese; Matthias Selbach; Thomas F Meyer; Steffen Backert
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways.

Authors:  Stefan Moese; Matthias Selbach; Terry Kwok; Volker Brinkmann; Wolfgang König; Thomas F Meyer; Steffen Backert
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 4.  The versatile bacterial type IV secretion systems.

Authors:  Eric Cascales; Peter J Christie
Journal:  Nat Rev Microbiol       Date:  2003-11       Impact factor: 60.633

5.  A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology.

Authors:  Christiane Pelz; Sylvia Steininger; Claudia Weiss; Fabian Coscia; Roger Vogelmann
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

Review 6.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

Review 7.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 8.  The role of Helicobacter pylori CagA in gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

9.  Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR.

Authors:  Richard H Argent; Youli Zhang; John C Atherton
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

Review 10.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.